CVS - Company ID 0000064803
The table below shows CVS HEALTH Corp's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $100.43B | $102.87B | $98.92B | $94.59B | $95.43B | $91.23B |
| Cost of revenue | $55.44B | $57.05B | $54.01B | $51.06B | $52.95B | $50.00B |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
CVS HEALTH Corp reported annual revenue of $402.07B for fiscal year 2025. That is up 7.8% from $372.81B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $177.55B (FY 2016) to $402.07B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| - |
| - |
| - |
| - |
| - |
| - |
| Operating income | $4.68B | -$3.21B | $2.38B | $3.37B | $832.00M | $3.04B |
| Income tax | $981.00M | $508.00M | $634.00M | $835.00M | $34.00M | $569.00M |
| Net income | $2.94B | -$3.98B | $1.02B | $1.78B | $87.00M | $1.77B |
| EPS (diluted) | $2.30 | -$3.13 | $0.80 | $1.41 | $0.07 | $1.41 |